Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease

René Pfeifle(Friedrich-Alexander-Universität Erlangen-Nürnberg), Gerhard Krönke(Friedrich-Alexander-Universität Erlangen-Nürnberg)

Nature Immunology

November 7, 2016

10.1038/ni.3579

Cited by 311

Related Papers

12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis

|The Journal of Immunology|2009|163

Bispecific T cell engager therapy for refractory rheumatoid arthritis

|Nature Medicine|2024|147

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

|The Lancet|2024|134

Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs

|Arthritis Research & Therapy|2021|60

Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis - an explorative qualitative study

|BMC Health Services Research|2022|28